BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//ACC//Meetings//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011101T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD BEGIN:DAYLIGHT DTSTART:16010301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\n\n\n\nWebinar Overview\nDiscover the foundations\, clinical a pplications and implementation of myocardial PET perfusion imaging\, with a special focus on veterans' cardiac care and the new tracer Flurpiridaz.\ nJoin ACC's Federal Cardiology Member Section for a webinar providing lear ners with an up-to-date foundational knowledge of myocardial PET perfusion imaging and its clinical applications in cardiac care. Content will inclu de an overview of clinical use criteria\, a comparison of single-photon em ission computed tomography (SPECT) and PET perfusion modalities\, and disc ussion of the newly U.S. Food and Drug Administration-approved tracer\, Fl urpiridaz\, and its role in clinical practice. Special focus will be place d on veterans as a unique patient population\, highlighting how myocardial PET perfusion can offer particular benefits in this group. Patient case s tudies will be used to demonstrate real-world applications\, illustrating how PET imaging informs diagnosis and optimizes clinical decision-making. The session will also address operational considerations: current availabi lity of PET within the Veterans Affairs (VA) system\, barriers to broader implementation\, and practical guidance on initiating a new myocardial PET perfusion program.\nKey Objectives/Learning Outcomes: \n\nDescribe the ap propriate use criteria for myocardial PET perfusion study\, and difference s between PET and SPECT.\nApply patient selection criteria to identify vet eran patient populations who would benefit most from myocardial PET perfus ion imaging and incorporate this modality into patient decision algorithms .\nInterpret results of myocardial PET perfusion study in case-based scena rios and integrate findings into patient management decisions.\nOutline ba sic resources needed for a PET perfusion program within the VA and the U.S . Department of Defense.\n\n\nWebinar Recording\n\n\n\n\nWebinar Participa nts\nModerator - Helme Silvet\, MD\, FACC\nSpeaker - David Bushnell\, MD\n Speaker - Nishant R. Shah\, MD\, FACC\nSpeaker - Filipe Moura\, MD\n\n\nVi ew Credit Information\n\n\n Joint Accreditation Statement\n\nIn support of improving patient care\, the American College of Cardiology Foundation (A CCF) is jointly accredited by the Accreditation Council for Continuing Med ical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide co ntinuing education for the healthcare team.\n\nCredit Designation Statemen ts\n\nPhysicians\nThe ACCF designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the act ivity. \n\nNurses\nThe ACCF designates this educational activity for a max imum of 1 continuing nursing education contact hour.\n\n\nPhysician Associ ates\nThe American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit fo r activities planned in accordance with AAPA CME Criteria. This activity i s designated for 1 AAPA Category 1 CME credit. PAs should only claim credi t commensurate with the extent of their participation.\n\n\nIPCE\nThis act ivity was planned by and for the healthcare team\, and learners will recei ve 1 Interprofessional Continuing Education (IPCE) credits for learning an d change.\n\nDisclaimer Statement \nThis information is provided for gener al medical education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and tre atment options for a specific patient's medical condition. The American Co llege of Cardiology Foundation (ACCF) does not warrant the completeness\, accuracy or usefulness of any opinions\, advice\, services or other inform ation provided through this activity. In no event will ACCF be liable for any decision made\, or action taken\, in reliance upon the information pro vided through this activity. Accredited status does not imply endorsement by ACC of any commercial products displayed in conjunction with this activ ity. ACCF reserves the right to modify faculty and program without notice. \n\nDisclosure Information\n\nDisclosure/Conflict of Interest Statement \n As a provider jointly accredited by the Accreditation Council for Continui ng Medical Education (ACCME)\, the Accreditation Council for Pharmacy Educ ation (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, the A merican College of Cardiology Foundation (ACCF) must ensure balance\, inde pendence\, objectivity\, and scientific rigor in all of their directly pro vided or jointly provided/co-provided educational activities. Planners\, p resenters\, and other contributors\, in a position to control the content are required to disclose to the audience all relevant financial relationsh ips he/she and/or his/her spouse or domestic partner may have\, occurring within the past 24 months\, with any entity producing\, marketing\, re-sel ling\, or distributing health care goods or services consumed by\, or used on\, patients. When an unlabeled use of a commercial product or an invest igational use not yet approved for any purpose is discussed during an educ ational activity\, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investi gational. ACCF is committed to providing its learners with high-quality ac tivities and materials that promote improvements and quality in health car e and not a specific proprietary business or commercial interest. The inte nt of this disclosure is not to prevent participation in educational activ ities by persons with a financial or other relationship\, but rather to pr ovide learners with information on which they can make their own determina tion whether financial interests or relationships may influence the educat ion activity. ACCF assesses conflicts of interest (COI) with its faculty\, planners\, managers\, staff\, and other individuals who are in a position to control the content of certified activities. All relevant potential co nflicts of interest that are identified are thoroughly vetted by course di rectors\, ACCF education staff\, and members of the Accreditation Complian ce Workgroup (ACWG) through a process that includes appropriate peer revie w for fair balance\, scientific objectivity and validity\, and patient car e and safety recommendations. ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated. Please not e ACCF staff and the ACWG members involved with this activity have nothing to disclose\, unless otherwise noted. \n\nProgram Committee\n\nElizabeth Le\, MD\, FACC \nOregon Health and Sciences University Hospital \nDr. Le h as disclosed that she has no actual or potential conflicts of interest in regard to this program\n\nFaith Kelly\, MD\, FACC \nBrooke Army Medical Ce nter \nDr. Kelly has disclosed that she has no actual or potential conflic ts of interest in regard to this program \n\nAli E. Denktas\, MD\, FACC \n Baylor Saint Lukes Medical Center \nDr. Denktas has disclosed that he has no actual or potential conflicts of interest in regard to this program\n\n Helme Silvet\, MD\, FACC\nVA Loma Linda Healthcare System\nDr. Silvet has disclosed that he has no actual or potential conflicts of interest in rega rd to this program\n \nFaculty\n\nFilipe A. Moura\, MD\nYale New Haven Hos pital\nDr. Moura has disclosed that he has no actual or potential conflict s of interest in regard to this program \n\nNishant R. Shah\, MD\, FACC\nD uke Health\nConsultant Fees/Honoraria - BridgeBio\, Pfizer\, Inc\nResearch /Research Grants – Pfizer\, Inc\n\nDavid Bushnell\, MD\nUniversity of Iowa Healthcare\nOther – Ebix/Oakstone\n\nHelme Silvet\, MD\, FACC \nVA Loma L inda Healthcare System\nDr. Silvet has disclosed that he has no actual or potential conflicts of interest in regard to this program\n\nCredit & Cour se Evaluation\nYour feedback from this American College of Cardiology (ACC ) educational course will help us to better target ACC educational initiat ives and efforts to support you and your future learning needs. In order t o receive your CME certificate or certificate of attendance\, you must com plete a brief evaluation survey online. This survey will be sent via email and will include a direct link to the survey. We strongly recommend that evaluations and credit claims be submitted within one month of the course\ , but you must complete them within three months of the course.\n\n\n-->\n \n\n\n\n\n .videoWrapper {\n position: relative\;\n padding-botto m: 56.25%\; /* 16:9 */\n padding-top: 25px\;\n height: 0\;\n }\n .videoWrapper iframe {\n position: absolute\;\n top: 0\;\n lef t: 0\;\n width: 100%\;\n height: 100%\;\n }\n\n DTEND;TZID=Eastern Standard Time:20251120T191500 DTSTAMP:20260428T214153Z DTSTART;TZID=Eastern Standard Time:20251120T190000 LOCATION:Online - Eastern Time (ET) SEQUENCE:0 SUMMARY:From SPECT to PET: Optimizing Myocardial Perfusion in Federal Healt h Care UID:50e068c4-d924-4176-9938-a4c5e129ca55@acc.org X-ALT-DESC;FMTTYPE=text/html:\n
\n
\n\n

Webinar Over view

\n

Discover the foundations\, clinical a pplications and implementation of myocardial PET perfusion imaging\, with a special focus on veterans' cardiac care and the new tracer Flurpiridaz.< /p>\n

Join ACC's Federal Cardiology Member Section for a webinar providing learners with an up-to-date foundational knowledge of my ocardial PET perfusion imaging and its clinical applications in cardiac ca re. Content will include an overview of clinical use criteria\, a comparis on of single-photon emission computed tomography (SPECT) and PET perfusion modalities\, and discussion of the newly U.S. Food and Drug Administratio n-approved tracer\, Flurpiridaz\, and its role in clinical practice. Speci al focus will be placed on veterans as a unique patient population\, highl ighting how myocardial PET perfusion can offer particular benefits in this group. Patient case studies will be used to demonstrate real-world applic ations\, illustrating how PET imaging informs diagnosis and optimizes clin ical decision-making. The session will also address operational considerat ions: current availability of PET within the Veterans Affairs (VA) system\ , barriers to broader implementation\, and practical guidance on initiatin g a new myocardial PET perfusion program.

\n

K ey Objectives/Learning Outcomes:

\n
    \n
  1. D escribe the appropriate use criteria for myocardial PET perfusion study\, and differences between PET and SPECT.
    2. \n
  2. Apply patient selection c riteria to identify veteran patient populations who would benefit most fro m myocardial PET perfusion imaging and incorporate this modality into pati ent decision algorithms.
    3. \n
  3. Interpret results of myocardial PET per fusion study in case-based scenarios and integrate findings into patient m anagement decisions.
    4. \n
  4. Outline basic resources needed for a PET pe rfusion program within the VA and the U.S. Department of Defense.
    5. \n\n\n

    Webinar Recording

    \n
    \n\n
    \n\n

    Webinar Participants

    \n

    Moderator - Helme Silvet\, MD\, FACC
    \nSpeaker - David Bushnell\, MD
    \nSpeaker - Nishant R. Shah\, MD\, FACC
    \nSpeaker - Filipe Moura\, MD

    \n\n

    \n\n
\n\n
\n